10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2024-02-14 (Q4 2023) | Holdings: 62 | Value: $6.4B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | Reduce 6% $(77.1M) | 19.88% | $1.3B | +21.50% | -15.12% | +6.88% | |
| IMGN - IMMUNOGEN INC | Add 78% ($309.2M) | 11.00% | $704.2M | ||||
| PCVX - VAXCYTE INC | 7.74% | $495.6M | -53.06% | -3.39% | +11.24% | ||
| LEGN - LEGEND BIOTECH CORP-ADR | 5.89% | $376.9M | -46.15% | -21.72% | -34.62% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | Reduce 6% $(15.9M) | 3.83% | $245.0M | +31.36% | -21.40% | +14.23% | |
| AVTE - AEROVATE THERAPEUTICS INC | 2.92% | $187.0M | +7.80% | -87.84% | |||
| INBX - INHIBRX INC | 2.80% | $179.5M | |||||
| CBAY - CYMABAY THERAPEUTICS INC | 2.56% | $163.9M | |||||
| BIIB - BIOGEN INC | 2.15% | $137.9M | -41.05% | +6.41% | -38.25% | ||
| RXST - RXSIGHT INC | Add 12% ($14.2M) | 2.14% | $137.3M | -71.68% | +22.02% | -41.54% | |
| ETNB - 89BIO INC | 1.99% | $127.5M | +0.81% | -6.88% | +10.53% | ||
| VRNA - VERONA PHARMA PLC - ADR | 1.96% | $125.6M | +386.85% | -20.60% | +265.68% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 1.78% | $114.0M | -53.32% | +10.28% | -19.88% | ||
| ANTX - AN2 THERAPEUTICS INC | 1.78% | $113.7M | -71.90% | -42.53% | -71.14% | ||
| TYRA - TYRA BIOSCIENCES INC | 1.57% | $100.2M | -46.95% | -3.81% | -34.32% | ||
| JANX - JANUX THERAPEUTICS INC | 1.54% | $98.3M | +172.09% | +421.76% | +307.58% | ||
| GERN - GERON CORP | 1.52% | $97.5M | -26.07% | +84.83% | +24.64% | ||
| ICVX - ICOSAVAX INC | 1.47% | $94.0M | |||||
| ALPN - ALPINE IMMUNE SCIENCES INC | Add 5% ($4.2M) | 1.46% | $93.6M | +114.78% | |||
| WVE - WAVE LIFE SCIENCES LTD | Add 6% ($5.0M) | 1.44% | $91.9M | +82.43% | +59.46% | +198.11% | |
| NAMS - NEWAMSTERDAM PHARMA CO NV | Reduce 13% $(12.7M) | 1.37% | $87.8M | -2.94% | -1.44% | -0.30% | |
| FDMT - 4D MOLECULAR THERAPEUTICS IN | 1.32% | $84.3M | -86.12% | -9.16% | -82.78% | ||
| EVH - EVOLENT HEALTH INC - A | Reduce 7% $(6.2M) | 1.32% | $84.2M | -73.75% | -24.52% | -67.56% | |
| AXSM - AXSOME THERAPEUTICS INC | 1.24% | $79.6M | +16.48% | -20.07% | +34.83% | ||
| FULC - FULCRUM THERAPEUTICS INC | 1.22% | $78.4M | -22.89% | -10.52% | -59.11% | ||
| CTKB - CYTEK BIOSCIENCES INC | New Purchase | 0.97% | $62.1M | -61.30% | -29.32% | -38.47% | |
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.90% | $57.3M | -66.87% | +17.65% | -55.11% | ||
| PEPG - PEPGEN INC | 0.86% | $55.3M | -89.73% | +0.00% | -89.87% | ||
| APGE - APOGEE THERAPEUTICS INC | 0.86% | $55.3M | +5.23% | +48.97% | -2.38% | ||
| SPRY - ARS PHARMACEUTICALS INC | 0.81% | $51.8M | +88.50% | +24.54% | +65.08% | ||
| NKTX - NKARTA INC | New Purchase | 0.80% | $51.5M | -82.44% | -33.97% | -78.21% | |
| VOR - VOR BIOPHARMA INC | 0.80% | $51.2M | -89.15% | -15.53% | -30.58% | ||
| ITOS - ITEOS THERAPEUTICS INC | 0.76% | $48.4M | +0.20% | +76.77% | -26.77% | ||
| MDGL - MADRIGAL PHARMACEUTICALS INC | 0.74% | $47.3M | +26.00% | -2.67% | +56.23% | ||
| URGN - UROGEN PHARMA LTD | Add 108% ($24.0M) | 0.72% | $46.3M | -73.26% | -28.30% | -45.06% | |
| MGNX - MACROGENICS INC | New Purchase | 0.61% | $39.0M | -91.42% | -72.11% | -83.07% | |
| ELYM - ELIEM THERAPEUTICS INC | 0.55% | $35.5M | -52.31% | +207.31% | -41.15% | ||
| TSHA - TAYSHA GENE THERAPIES INC | 0.51% | $32.7M | +98.62% | +114.48% | +10.34% | ||
| GHRS - GH RESEARCH PLC | 0.51% | $32.4M | +55.10% | +56.70% | +72.26% | ||
| ELVN - ENLIVEN THERAPEUTICS INC | 0.46% | $29.4M | +23.53% | +38.73% | +26.13% | ||
| CCCC - C4 THERAPEUTICS INC | New Purchase | 0.43% | $27.6M | -80.37% | -18.42% | -60.35% | |
| MLYS - MINERALYS THERAPEUTICS INC | 0.43% | $27.3M | +4.34% | -12.69% | -35.87% | ||
| HOWL - WEREWOLF THERAPEUTICS INC | 0.37% | $23.7M | -79.60% | -19.57% | -75.95% | ||
| ACRV - ACRIVON THERAPEUTICS INC | 0.37% | $23.7M | -63.45% | +152.92% | +53.80% | ||
| PLRX - PLIANT THERAPEUTICS INC | Reduce 27% $(8.7M) | 0.36% | $23.2M | -90.48% | -9.22% | -82.39% | |
| THRD - THIRD HARMONIC BIO INC | New Purchase | 0.35% | $22.3M | -44.63% | +35.23% | -63.47% | |
| RNA - AVIDITY BIOSCIENCES INC | Reduce 62% $(35.9M) | 0.35% | $22.2M | +159.21% | +114.93% | +133.07% | |
| SLDB - SOLID BIOSCIENCES INC | New Purchase | 0.33% | $21.0M | -53.90% | +5.10% | -42.52% | |
| GPCR - STRUCTURE THERAPEUTICS INC | New Purchase | 0.31% | $19.8M | -53.28% | -21.50% | -50.55% | |
| TNYA - TENAYA THERAPEUTICS INC | Reduce 18% $(3.9M) | 0.28% | $17.8M | -91.07% | -29.75% | -81.16% | |
| ACRS - ACLARIS THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| BCYC - BICYCLE THERAPEUTICS PLC-ADR | Reduce 100% | 0.00% | $0.00 | ||||
| COGT - COGENT BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| EYPT - EYEPOINT PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SLNO - SOLENO THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| VRDN - VIRIDIAN THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CVAC - CUREVAC NV | Reduce 100% | 0.00% | $0.00 | ||||